IN-VITRO PRODUCTION OF HIV-SPECIFIC ANTIBODY IN CHILDREN AT RISK OF AIDS
Open Access
- 1 April 1988
- journal article
- research article
- Published by Elsevier in The Lancet
- Vol. 331 (8590), 852-854
- https://doi.org/10.1016/s0140-6736(88)91603-0
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- HIV-mediated immunodepression: in vitro inhibition of T-lymphocyte proliferative response by ultraviolet-inactivated virusClinical Immunology and Immunopathology, 1988
- INFANTS BORN TO MOTHERS SEROPOSITIVE FOR HUMAN IMMUNODEFICIENCY VIRUSThe Lancet, 1987
- Persistent HIV antigenaemia and decline of HIV core antibodies associated with transition to AIDS.BMJ, 1986
- HTLV-III and HTLV-I infection in populations at risk in the veneto region of ItalyEuropean Journal of Cancer and Clinical Oncology, 1986
- Defective Regulation of Epstein–Barr Virus Infection in Patients with Acquired Immunodeficiency Syndrome (AIDS) or AIDS-Related DisordersNew England Journal of Medicine, 1986
- Tolerance to viral antigens in Mov-13 mice carrying endogenized moloney-murine leukemia virusCellular Immunology, 1984
- Abnormalities of B-Cell Activation and Immunoregulation in Patients with the Acquired Immunodeficiency SyndromeNew England Journal of Medicine, 1983
- Identification, purification, and characterization of antigen-activated and antigen-specific human B lymphocytes.The Journal of Experimental Medicine, 1983
- Maturation of B-Cell Differentiation Ability and T-Cell Regulatory Function in Infancy and ChildhoodImmunological Reviews, 1981
- Humoral and Cellular Immunity in Humans Studied at the Cell Level from Birth to Two Years of AgeImmunological Reviews, 1981